- ZIOP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $62.5 million.
- ZIOP is up 8.7% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ZIOP with the Ticky from Trade-Ideas. See the FREE profile for ZIOP NOW at Trade-Ideas More details on ZIOP: ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. Currently there are 2 analysts that rate ZIOPHARM Oncology a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for ZIOPHARM Oncology has been 3.9 million shares per day over the past 30 days. ZIOPHARM Oncology has a market cap of $1.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.71 and a short float of 27.9% with 6.59 days to cover. Shares are up 111.4% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.